Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 691-700

  Haffty, B G ^a   Ward, B ^a   Pathare, P ^a   Salem, R ^a   McKhann, C ^a   Beinfield, M ^a   Fischer, D ^a   Reiss, M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031019753     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.691     Document Type: Article

References (43)

1. Fisher B, Redmond C, Fischer ER, et al.: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985
2. Rutqvist LE, Cedermark B, Glas U, et al.: Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Int J Radiat Oncol Biol Phys 16:629-639, 1989
3. Fisher B, Wolmark N, Bauer M, et al.: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-772, 1981
4. Atkins H, Hayward JL, Klugman D, et al.: Treatment of early breast cancer, a report after ten years of a clinical trial. Br Med J 2:423-427, 1972
5. Solin LJ, Fowble BL, Schultz DJ, et al.: The impact of mammography on the patterns of patients referred for definitive breast irradiation. Cancer 65:1085-1088, 1990
6. Shapiro S: Determining the efficacy of breast cancer screening. Cancer 63:1873-1880, 1990
7. Cody HS: The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993: Equal value for patients younger and older than age 50 years. Cancer 9:1579-1584, 1995
8. Schwartz GF, Carter DL, Conant EF, et al.: Mammographically detected breast cancer. Cancer 73:1660-1665, 1994
9. Cady B: Approach to mammographically discovered small breast cancer. Breast J 2:56-58, 1996
10. Kopans D, Halpern E, Hulka C: Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 74:1196-1216, 1994
11. Fisher B, Redmond C, Poisson R, et al.: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
12. Veronesi U, Sacozzi R, Del Vecchio M, et al.: Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl M Med 305:6-11, 1981
13. Haffty BG, Fischer D, Rose M, et al.: Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data. J Clin Oncol 9:997-1003, 1991
14. Fowble B, Solin LJ, Schultz DJ: Conservative surgery and radiation for early breast cancer, in Fowble B, Goodman RL, Glick JH, et al. (eds). Breast Cancer Treatment. A Comprehensive Guide to Management. St Louis, MO, Mosby, 1991, pp 3-88
15. Harris J, Recht A, Almaric R, et al.: Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol 2:37-41, 1984.
16. Early Breast Cancer Trialists Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. One hundred thirty three randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1-15, 71-85, 1992
17. Bonadonna G, Valagussa P, Moliterni A, et al.: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. The results of 20 years of follow-up. N Engl J Med 330:1253-59, 1995
18. Fisher B, Redmond C, Dimitriov N, et al.: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen receptor negative tumors. N Engl J Med 320:473-478, 1989
19. Fisher B, Constantino J, Redmond C, et al.: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor positive tumors. N Engl J Med 320:479-484, 1989
20. The Ludwig Breast Cancer Group: Prolonged disease-free survival after one course of postoperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491-496, 1989
21. Mansour E, Gray R, Shatila A, et al.: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. N Engl J Med 320:485-490, 1989
22. Haffty BG, McKhann C, Beinfield M, et al.: Breast conservation therapy without axillary dissection. A rational treatment strategy in selected patients. Arch Surg 128:1315-1319, 1993
23. Recht A, Pierce SM, Abner A, et al.: Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9:988-996, 1991
24. Dewar JA, Sarrazin D, Benhamou E, et al.: Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 13:475-481, 1987
25. Cabanes PA, Salmon RJ, Vilcoq, et al.: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339:1245-1248, 1992
26. Wazer DE, Erban JK, Robert NJ, et al.: Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 74:878-883, 1994
27. Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer. A review. Cancer 76:1491-1512, 1995
28. Morrow M: Axillary node dissection: What role in managing Bca? Contemp Oncol August: 16-27, 1994
29. Larson D, Weinstein M, Goldberg I, et al.: Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12:1575-1582, 1986
30. Tobin MB, Lacey HJ, Meyer L, et al.: The psychological morbidity of breast cancer-related arm swelling: Psychological morbidity of lymphoedema. Cancer 72:3248-3252, 1993
31. Pezner RD, Patterson MP, Hill LR: Arm edema in patients treated conservatively for breast cancer: Relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys 12:2079-2083, 1986
32. Silverstein MJ, Gierson ED, Waisman JR: Axillary lymph node dissection for T1a breast carcinoma. Cancer 73:664-667, 1994
33. Ravdin PM, De Laurentiis M, Vendely T, et al.: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 86:1771-1775, 1994
34. Haffty BG, Fischer D, Fischer JJ: Regional nodal irradiation in the conservative treatment of breast cancer. Int J Radial Oncol Biol Phys 19:859-865, 1990
35. Rosen PP, Groshen S, Kinne D, et al.: Factors influencing prognosis in node-negative breast carcinomas: Analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 11:2090-2100, 1993
36. McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326:1756-1761, 1992
37. Kaplan FL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-486, 1958
38. Fisher B, Mamounas EP: Preoperative chemotherapy: A model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13:537-540, 1995
39. Powles TJ, Hickish TF, Makris A, et al.: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13:547-552, 1995
40. Scholl SM, Fourquet A, Asselain B, et al.: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur J Cancer 30A:645-652, 1994
41. Khalkhali I: New horizons in breast imaging: A complementary role of technetium 99m sestamibi for the diagnosis and staging of breast carcinoma. Breast J 2:23-25, 1996
42. Giuliano A, Dale P, Turner R, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995
43. Krag DN, Weaver DL, Alex JC, et al.: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using gamma probe. Surg Oncol 2:335-340, 1993